Wolverine Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,500
Closed -$922K 1622
2024
Q4
$922K Hold
2,500
0.01% 718
2024
Q3
$1.3M Sell
2,500
-1,400
-36% -$748K 0.01% 620
2024
Q2
$2.11M Buy
+3,900
New +$2.06M 0.02% 489
2015
Q3
Sell
-3
Closed -$3K 1842
2015
Q2
$3K Hold
3
﹤0.01% 1717
2015
Q1
$2K Buy
+3
New +$427 ﹤0.01% 1705
2014
Q4
Sell
-17
Closed -$31K 2275
2014
Q3
$31K Sell
17
-5
-23% -$573 ﹤0.01% 1670
2014
Q2
$16K Sell
22
-21
-49% -$2.16K ﹤0.01% 1741
2014
Q1
$34K Buy
43
+33
+330% +$2.98K ﹤0.01% 1469
2013
Q4
$12K Sell
10
-38
-79% -$3.38K ﹤0.01% 2196
2013
Q3
$55K Sell
48
-326
-87% -$27.9K ﹤0.01% 1687
2013
Q2
$248K Buy
+374
New +$28K 0.01% 1029

Other funds holding ELV

Wolverine Asset Management's ELV Position: Q1 2025 in Review

Wolverine Asset Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 13,282 shares — an estimated $4.9M sold.

Wolverine Asset Management first reported a position in ELV in Q2 2013 and held it in 15 quarters. The position peaked at $4.9M in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Wolverine Asset Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 13,282 Elevance Health shares in Q1 2025, an estimated $4.9M.
  • Wolverine Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 15 quarters.
  • Wolverine Asset Management's Elevance Health position peaked at $4.9M in Q4 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Wolverine Asset Management's 13F filing for Q1 2025, filed 12 May 2025.